BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29265141)

  • 1. To probe interaction of morphine and IBNtxA with 7TM and 6TM variants of the human μ-opioid receptor using all-atom molecular dynamics simulations with an explicit membrane.
    Sader S; Anant K; Wu C
    Phys Chem Chem Phys; 2018 Jan; 20(3):1724-1741. PubMed ID: 29265141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Truncated μ-Opioid Receptors With 6 Transmembrane Domains Are Essential for Opioid Analgesia.
    Lu Z; Xu J; Xu M; Rossi GC; Majumdar S; Pasternak GW; Pan YX
    Anesth Analg; 2018 Mar; 126(3):1050-1057. PubMed ID: 28991118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrapeptide Endomorphin Analogs Require Both Full Length and Truncated Splice Variants of the Mu Opioid Receptor Gene Oprm1 for Analgesia.
    Marrone GF; Lu Z; Rossi G; Narayan A; Hunkele A; Marx S; Xu J; Pintar J; Majumdar S; Pan YX; Pasternak GW
    ACS Chem Neurosci; 2016 Dec; 7(12):1717-1727. PubMed ID: 27648914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediation of opioid analgesia by a truncated 6-transmembrane GPCR.
    Lu Z; Xu J; Rossi GC; Majumdar S; Pasternak GW; Pan YX
    J Clin Invest; 2015 Jul; 125(7):2626-30. PubMed ID: 26011641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Characterization of Azido Aryl Analogs of IBNtxA for Radio-Photoaffinity Labeling Opioid Receptors in Cell Lines and in Mouse Brain.
    Grinnell SG; Uprety R; Varadi A; Subrath J; Hunkele A; Pan YX; Pasternak GW; Majumdar S
    Cell Mol Neurobiol; 2021 Jul; 41(5):977-993. PubMed ID: 32424771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Truncated mu opioid GPCR variant involvement in opioid-dependent and opioid-independent pain modulatory systems within the CNS.
    Marrone GF; Grinnell SG; Lu Z; Rossi GC; Le Rouzic V; Xu J; Majumdar S; Pan YX; Pasternak GW
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3663-8. PubMed ID: 26976581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic dissociation of morphine analgesia from hyperalgesia in mice.
    Marrone GF; Le Rouzic V; Varadi A; Xu J; Rajadhyaksha AM; Majumdar S; Pan YX; Pasternak GW
    Psychopharmacology (Berl); 2017 Jun; 234(12):1891-1900. PubMed ID: 28343361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Regulation of 6- and 7-Transmembrane Helix Variants of μ-Opioid Receptor in Response to Morphine Stimulation.
    Convertino M; Samoshkin A; Viet CT; Gauthier J; Li Fraine SP; Sharif-Naeini R; Schmidt BL; Maixner W; Diatchenko L; Dokholyan NV
    PLoS One; 2015; 10(11):e0142826. PubMed ID: 26554831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Truncated Six Transmembrane Splice Variant MOR-1G Enhances Expression of the Full-Length Seven Transmembrane
    Zhang T; Xu J; Pan YX
    Mol Pharmacol; 2020 Oct; 98(4):518-527. PubMed ID: 32723770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing biased activation of mu-opioid receptor by the biased agonist PZM21 using all atom molecular dynamics simulation.
    Liao S; Tan K; Floyd C; Bong D; Pino MJ; Wu C
    Life Sci; 2021 Mar; 269():119026. PubMed ID: 33444617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mu Opioids Induce Biased Signaling at the Full-Length Seven Transmembrane C-Terminal Splice Variants of the mu Opioid Receptor Gene, Oprm1.
    Narayan A; Hunkele A; Xu J; Bassoni DL; Pasternak GW; Pan YX
    Cell Mol Neurobiol; 2021 Jul; 41(5):1059-1074. PubMed ID: 33033993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediation of buprenorphine analgesia by a combination of traditional and truncated mu opioid receptor splice variants.
    Grinnell SG; Ansonoff M; Marrone GF; Lu Z; Narayan A; Xu J; Rossi G; Majumdar S; Pan YX; Bassoni DL; Pintar J; Pasternak GW
    Synapse; 2016 Oct; 70(10):395-407. PubMed ID: 27223691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional interactions between six-transmembrane μ-opioid receptors and β2-adrenoreceptors modulate opioid signaling.
    Samoshkin A; Convertino M; Viet CT; Wieskopf JS; Kambur O; Marcovitz J; Patel P; Stone LS; Kalso E; Mogil JS; Schmidt BL; Maixner W; Dokholyan NV; Diatchenko L
    Sci Rep; 2015 Dec; 5():18198. PubMed ID: 26657998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic characterization in the rat of a potent analgesic lacking respiratory depression, IBNtxA.
    Grinnell SG; Majumdar S; Narayan A; Le Rouzic V; Ansonoff M; Pintar JE; Pasternak GW
    J Pharmacol Exp Ther; 2014 Sep; 350(3):710-8. PubMed ID: 24970924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand based conformational space studies of the μ-opioid receptor.
    Sena DM; Cong X; Giorgetti A
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129838. PubMed ID: 33373630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dynamics of fentanyl bound to μ-opioid receptor.
    Lipiński PFJ; Jarończyk M; Dobrowolski JC; Sadlej J
    J Mol Model; 2019 May; 25(5):144. PubMed ID: 31053968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of aryl-naloxamide opiate analgesics targeting truncated exon 11-associated μ opioid receptor (MOR-1) splice variants.
    Majumdar S; Subrath J; Le Rouzic V; Polikar L; Burgman M; Nagakura K; Ocampo J; Haselton N; Pasternak AR; Grinnell S; Pan YX; Pasternak GW
    J Med Chem; 2012 Jul; 55(14):6352-62. PubMed ID: 22734622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Dynamics Simulations to Investigate How PZM21 Affects the Conformational State of the μ-Opioid Receptor Upon Activation.
    Zhao Z; Huang T; Li J
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Oliceridine (TRV-130) Binds and Stabilizes a μ-Opioid Receptor Conformational State That Selectively Triggers G Protein Signaling Pathways.
    Schneider S; Provasi D; Filizola M
    Biochemistry; 2016 Nov; 55(46):6456-6466. PubMed ID: 27778501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of novel candidate compounds targeting 6- and 7-transmembrane μ-opioid receptor isoforms.
    Muralidharan A; Samoshkin A; Convertino M; Piltonen MH; Gris P; Wang J; Jiang C; Klares R; Linton A; Ji RR; Maixner W; Dokholyan NV; Mogil JS; Diatchenko L
    Br J Pharmacol; 2021 Jul; 178(13):2709-2726. PubMed ID: 33782947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.